Almasry Pharmacy

Hemoline N Catage 100 Units Of 5 Vials Of 3 ml

Short Description:
Hemoline N Catage 100 Units Of 5 Vials Of 3 ml is a human insulin preparation for the management of diabetes mellitus, helping to control fasting and postprandial blood glucose. Supplied as 5 vials of 3 ml at 100 units/ml, it is designed for subcutaneous injection under medical supervision as part of a comprehensive diabetes care plan.

EGP 199

Out of Stock
We'll message you as soon as it's back in stock.
delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG010052
BrandهيمولاينLink Icon
Categories
Medication & Treatments
Color
black
Shop by ConcernsDiabetesLink Icon, High Blood SugarLink Icon, HyperglycemiaLink Icon
Gender
Unisex
Shop By GoalsBlood ThinningLink Icon, Diabetes ManagementLink Icon
Imported Or LocalLocal
Ingredient
Human insulin 100 units/ml
Specialty
Clinically Tested
Prescription only
Sub Categories
Insulin And Diabetic Medicines
Warning
Keep Out of Reach of Children
Do not freeze
Do not use during hypoglycemic episodes
Use under medical supervision
Risk of hypoglycemia
About the product›

Hemoline N Catage 100 Units Of 5 Vials Of 3 ml


Description:

Hemoline N Catage 100 Units is a human insulin preparation supplied as 5 multidose vials, each containing 3 ml. It is a prescription antidiabetic medication used to control blood glucose levels in patients with diabetes mellitus. The product name and category strongly suggest that it belongs to the insulin and diabetic medicines group, typically representing a neutral (isophane or mixed) insulin formulation. It is intended for subcutaneous injection as part of a comprehensive diabetes management plan that includes diet, exercise, and regular blood glucose monitoring. This product is suitable for adults and may be used in adolescents and children only under strict medical supervision.


Indications:

  • Management of diabetes mellitus requiring insulin therapy (type 1 diabetes and insulin‑requiring type 2 diabetes) as prescribed by a physician.
  • Control of fasting and postprandial blood glucose levels to help prevent hyperglycemia and related symptoms such as excessive thirst, frequent urination, fatigue, and blurred vision.
  • May be used in patients who are inadequately controlled on oral antidiabetic agents alone, according to physician judgment.
  • Prevention of long‑term diabetes complications (such as neuropathy, nephropathy, and retinopathy) when used as part of an overall glycemic control strategy.

Active Ingredients / Key Components:

  • Human insulin – 100 units/ml (exact insulin type and formulation are not specified in the available product information; commonly, such products are isophane or mixed human insulin, but the precise composition is unavailable).
  • Excipients – typical insulin vial excipients may include protamine, zinc, glycerol, metacresol, phenol, sodium chloride, and water for injections; however, the exact excipient list and concentrations for Hemoline N Catage are not available in the provided data.
  • Concentration: 100 units/ml (standard insulin strength), each vial 3 ml (total 300 units per vial), pack of 5 vials (total 1500 units per pack).

Dosage & Administration / How to Use:

  • Dosage must always be individualized by a healthcare professional based on blood glucose monitoring, type of diabetes, body weight, diet, physical activity, and concomitant medications.
  • Typical administration route: subcutaneous injection into the upper arm, thigh, buttock, or abdominal wall. Intravenous use is not recommended unless specifically directed and supervised by a physician in a clinical setting.
  • Injection technique: Rotate injection sites within the same region to reduce the risk of lipodystrophy and skin irritation. Do not inject into areas that are red, swollen, or damaged.
  • Timing of injections: The exact timing (e.g., once or multiple times daily, before meals or at bedtime) depends on the insulin regimen prescribed (basal, premixed, or combination therapy). Follow your doctor’s instructions carefully.
  • Inspect the solution before use: Do not use if the insulin appears discolored, contains particles, or shows clumping or precipitation inconsistent with its usual appearance.
  • Use a sterile insulin syringe or insulin pen/needle system compatible with vials, as instructed by your healthcare provider.
  • Do not change your dose, insulin type, or injection schedule without consulting your doctor or diabetes specialist.
  • If a dose is missed, check blood glucose and contact your healthcare provider for guidance; do not double the next dose without medical advice.

Clinical Benefits:

  • Helps achieve and maintain target blood glucose levels in patients with diabetes mellitus when used as prescribed.
  • Reduces symptoms of hyperglycemia such as excessive thirst, frequent urination, unexplained weight loss, and fatigue.
  • Supports long‑term protection against diabetes‑related complications affecting the eyes, kidneys, nerves, and cardiovascular system when combined with proper lifestyle and regular monitoring.
  • Provides a standardized insulin concentration of 100 units/ml, allowing accurate dosing and consistent glycemic control.
  • Pack of 5 vials offers a convenient supply for ongoing insulin therapy, reducing the need for frequent pharmacy visits.

Warnings & Contraindications:

  • For use only under medical supervision. Incorrect dosing or misuse of insulin can cause severe hypoglycemia or hyperglycemia, which may be life‑threatening.
  • Contraindicated in patients with known hypersensitivity to human insulin or any of the formulation components (exact excipients for this product are not specified; consult the package insert).
  • Do not use during episodes of hypoglycemia (low blood sugar). Treat hypoglycemia first according to your doctor’s instructions.
  • Use with caution in patients with renal or hepatic impairment, adrenal, pituitary, or thyroid disorders, and in those with irregular meal patterns or intense physical activity.
  • Alcohol consumption may enhance or reduce the blood glucose‑lowering effect of insulin; discuss safe use of alcohol with your doctor.
  • Beta‑blockers and other medications can mask hypoglycemia symptoms or alter insulin requirements. Inform your doctor about all medicines and supplements you are taking.
  • Pregnancy and breastfeeding: Insulin requirements may change during pregnancy and lactation. Consult your doctor to adjust doses and monitor blood glucose closely.
  • Do not share insulin vials, syringes, or needles with others to avoid transmission of infections.
  • Patients should be educated on recognizing and managing hypoglycemia (e.g., sweating, tremor, palpitations, confusion) and hyperglycemia (e.g., increased thirst, frequent urination, dry mouth).
  • Keep out of reach of children. Accidental injection or ingestion can be dangerous.

Side Effects:
  • Common: Hypoglycemia (low blood sugar) presenting with symptoms such as sweating, shakiness, hunger, headache, dizziness, palpitations, or confusion. Severe hypoglycemia can lead to loss of consciousness, seizures, or coma and requires immediate medical attention.
  • Local reactions at injection site: Redness, swelling, itching, or mild pain. These are usually transient but should be reported if persistent or severe.
  • Lipodystrophy (thickening or thinning of the skin/fat) at injection sites due to repeated injections in the same area.
  • Allergic reactions: Rash, itching, or more rarely generalized allergic reactions. Seek immediate medical help if you experience difficulty breathing, swelling of the face or throat, or severe rash.
  • Edema (fluid retention) or mild weight gain may occur when starting or intensifying insulin therapy.
  • If any unusual or severe side effects occur, or if blood glucose becomes difficult to control, contact your doctor immediately.

Storage Instructions:

Store unopened vials in a refrigerator at 2–8°c, away from the freezer compartment. Do not freeze. If insulin has been frozen, do not use it. Once in use, vials may be kept at room temperature as recommended by the manufacturer (exact in‑use storage duration for Hemoline N Catage is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); refer to the package insert). Protect from direct sunlight and excessive heat. Keep vials in their original carton until use to protect from light. Keep container tightly closed and out of reach of children.


Specifications:
  • Product type: Prescription antidiabetic medicine (insulin preparation).
  • Form: Injectable solution in vial for subcutaneous administration.
  • Strength: 100 units/ml (standard insulin concentration).
  • Pack size: 5 vials × 3 ml each (total 15 ml, equivalent to 1500 units of insulin).
  • Intended users: Adults and, where prescribed, adolescents and children under specialist supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp